de Truchis P - Search Results

1

High efficacy of first-line ART in a West African cohort, assessed by dried blood spot virological and pharmacological measurements.

de Truchis P, Lê MP, Daou M, Madougou B, Nouhou Y, Moussa Saley S, Sani A, Adehossi E, Rouveix E, Saidou M, Peytavin G, Delaugerre C. de Truchis P, et al. J Antimicrob Chemother. 2016 Nov;71(11):3222-3227. doi: 10.1093/jac/dkw286. Epub 2016 Jul 20. J Antimicrob Chemother. 2016. PMID: 27439522

2

Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapy.

Bernard L, Vuagnat A, Peytavin G, Hallouin MC, Bouhour D, Nguyen TH, Vildé JL, Bricaire F, Raguin G, de Truchis P, Ghez D, Duong M, Perronne C. Bernard L, et al. Among authors: de truchis p. Ann Intern Med. 2002 Oct 15;137(8):656-9. doi: 10.7326/0003-4819-137-8-200210150-00009. Ann Intern Med. 2002. PMID: 12379065

3

Key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients.

Delaugerre C, Mathez D, Peytavin G, Berthé H, Long K, Galperine T, de Truchis P. Delaugerre C, et al. Among authors: de truchis p. AIDS. 2007 May 31;21(9):1210-3. doi: 10.1097/QAD.0b013e32810fd744. AIDS. 2007. PMID: 17502734

4

Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial.

Duvivier C, Ghosn J, Assoumou L, Soulié C, Peytavin G, Calvez V, Génin MA, Molina JM, Bouchaud O, Katlama C, Costagliola D; ANRS 121 study group. Duvivier C, et al. J Antimicrob Chemother. 2008 Oct;62(4):797-808. doi: 10.1093/jac/dkn278. Epub 2008 Jul 18. J Antimicrob Chemother. 2008. PMID: 18641035 Clinical Trial.

5

Pattern and impact of emerging resistance mutations in treatment experienced patients failing darunavir-containing regimen.

Delaugerre C, Pavie J, Palmer P, Ghosn J, Blanche S, Roudiere L, Dominguez S, Mortier E, Molina JM, de Truchis P. Delaugerre C, et al. Among authors: de truchis p. AIDS. 2008 Sep 12;22(14):1809-13. doi: 10.1097/QAD.0b013e328307f24a. AIDS. 2008. PMID: 18690163

6

Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France.

Chaix ML, Descamps D, Wirden M, Bocket L, Delaugerre C, Tamalet C, Schneider V, Izopet J, Masquelier B, Rouzioux C, Meyer L, Costagliola D; ANRS AC11 Resistance Group; Cohort PRIMO ANRS CO 6; FHDH ANRS CO4 Study Groups. Chaix ML, et al. AIDS. 2009 Mar 27;23(6):717-24. doi: 10.1097/QAD.0b013e328326ca77. AIDS. 2009. PMID: 19279445

7

Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial.

Gallien S, Braun J, Delaugerre C, Charreau I, Reynes J, Jeanblanc F, Verdon R, de Truchis P, May T, Madelaine-Chambrin I, Aboulker JP, Molina JM; EASIER ANRS 138 Study Group. Gallien S, et al. Among authors: de truchis p. J Antimicrob Chemother. 2011 Sep;66(9):2099-106. doi: 10.1093/jac/dkr269. Epub 2011 Jun 28. J Antimicrob Chemother. 2011. PMID: 21712241 Clinical Trial.

8

Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients.

Delaugerre C, Gallien S, Flandre P, Mathez D, Amarsy R, Ferret S, Timsit J, Molina JM, de Truchis P. Delaugerre C, et al. Among authors: de truchis p. PLoS One. 2012;7(5):e36673. doi: 10.1371/journal.pone.0036673. Epub 2012 May 10. PLoS One. 2012. PMID: 22590588 Free PMC article. Clinical Trial.

9

[Aging and HIV infection: 4 years follow-up of 149 HIV infected patients older than 60 years in West Paris agglomeration (COREVIH Île-de-France Ouest)].

Flexor G, Zucman D, Berthé H, Meier F, Force G, Greder-Belan A, Billy C, Dupont C, Mortier E, Bizard A, Rouveix E, de Truchis P; le COREVIH Île-de-France Ouest. Flexor G, et al. Among authors: de truchis p. Presse Med. 2013 May;42(5):e145-52. doi: 10.1016/j.lpm.2012.11.005. Epub 2013 Feb 20. Presse Med. 2013. PMID: 23433913 French.

10

Transmitted drug resistance in French HIV-2-infected patients.

Charpentier C, Visseaux B, Bénard A, Peytavin G, Damond F, Roy C, Taieb A, Chêne G, Matheron S, Brun-Vézinet F, Descamps D; ANRS CO5 HIV-2 Cohort. Charpentier C, et al. AIDS. 2013 Jun 19;27(10):1671-4. doi: 10.1097/QAD.0b013e32836207f3. AIDS. 2013. PMID: 23595155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters